Collectively, the observation of the role of the CTLA4 −6230 polymorphism and the occurrence of a haplotype/diplotype bearing the CTLA4A variant in pulmonary TB indicates that a reduced CTLA-4 activity in humans does not enhance protection against pulmonary TB but enhances pathology if containment of the infection fails. This evidence concerns the gene CTLA4 and infection.